Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

We aimed to examine the relationship between renal dysfunction and anaemia that may develop during combination therapy involving pegylated interferon, ribavirin and telaprevir (PEG-IFN/RBV/TVR) for the treatment of chronic hepatitis C. Sixty-eight patients with genotype 1b high viral loads were trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Viral Hepat
Autors principals: Karino, Y, Ozeki, I, Hige, S, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2014
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282353/
https://ncbi.nlm.nih.gov/pubmed/24001168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.12162
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars